| [1] |
Scopinaro N. The IFSO and obesity surgery throughout the world. International Federation for the Surgery of Obesity[J]. Obesity Surgery, 1998, 8(1): 3-8.
|
| [2] |
Buchwald H, Oien DM. Metabolic/Bariatric Surgery Worldwide 2008[J]. Obesity Surgery, 2009, 19(12): 1605-1611.
URL
|
| [3] |
Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery Worldwide 2013[J]. Obesity Surgery, 2015, 25(10): 1822-1832.
|
| [4] |
Angrisani L, Santonicola A, Iovino P, et al. Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014[J]. Obesity Surgery, 2017, 27(9): 2279-2289.
|
| [5] |
Luca MD, Tie T, Ooi G, et al. Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement[J]. Obesity Surgery, 2018, 28(6): 1188-1206.
|
| [6] |
Luigi A, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures[J]. Obesity Surgery, 2018, 28(12): 3783-3794.
|
| [7] |
蔡景理，郑成竹，陈丹磊，等．腹腔镜迷你胃旁路术治疗单纯性肥胖并2型糖尿病[J]．中国实用外科杂志，2008，28(3)：197-199．
|
| [8] |
刘洋，李梦伊，张萌，等．单吻合口胃旁路术治疗病态肥胖症56例疗效分析[J]．中国实用外科杂志，2020，40(04)：426-428．
|
| [9] |
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y Versus Mini-Gastric Bypass for the Treatment of Morbid Obesity[J]. Annals of Surgery, 2005, 242(1): 20-28.
|
| [10] |
中华医学会外科学分会甲状腺及代谢外科学组，中国医师协会外科医师分会肥胖和糖尿病外科医师委员会．中国肥胖及2型糖尿病外科治疗指南(2019版)[J]．中国实用外科杂志，2019，39(4)：301-306．
|
| [11] |
Chen CY, Lee WJ, Lee HM, et al. Laparoscopic Conversion of Gastric Bypass Complication to Sleeve Gastrectomy: Technique and Early Results[J]. Obesity Surgery, 2016, 26(9): 2014-2021.
|
| [12] |
Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass[J]. Surgery for Obesity and Related Diseases, 2011, 7(4): 486-491.
URL
|
| [13] |
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y Vs. Mini-gastric Bypass for the Treatment of Morbid Obesity: a 10-Year Experience[J]. Obesity Surgery, 2012, 22(12): 1827-1834.
URL
|
| [14] |
Alkhalifah N, Lee WJ, Tan CH, et al. 15-year experience of lapa-roscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures[J]. Surgery Endoscopy, 2018, 32(6): 3024-3031.
|
| [15] |
Mingrone, Geltrude, Panunzi, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial[J]. Obésité, 2018, 386(9997): 964-973.
|
| [16] |
Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data[J]. Surgery for Obesity & Related Diseases Official Journal of the American Society for Bariatric Surgery, 2016, 11(6)1697.
|
| [17] |
Lee WJ, Wang W, Lee YC, et al. Laparoscopic Mini-gastric Bypass: Experience with Tailored Bypass Limb According to Body Weight[J]. Obesity Surgery, 2008, 18(3): 294-299.
URL
|
| [18] |
Chen JC, Shen CY, Lee WJ, et al. Protein deficiency after gastric bypass: the role of common limb length in revision surgery[J]. Obesity Surgery, 2019, 15(3):,441-446.
|
| [19] |
Owaid M, Almalki, WeiJei Lee, et al Laparoscopic gastric bypass for the treatment of type 2 diabetes: A comparison of roux-en-Y versus single anastomosis gastric bypass[J]. Surgery for Obesity & Related Diseases, 2018, 14(4): S128-S129.
|
| [20] |
Wang FG, Yan WM, Yan M, et al. Outcomes of Mini vs Roux-en-Y gastric bypass: A meta-analysis and systematic review[J]. International Journal of Surgery (London, England), 2018, 56: 7-14.
|
| [21] |
Yingjun Q, Ao H, Min Y, et al. Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis[J]. Gastroenterology Research & Practice, 2015, 2015: 152852.
|
| [22] |
BhandariM, Nautiyal HK, Kosta S, et al. Comparison of one anas-tomosis gastric bypass (OAGB) and roux-en-Y gastric bypass (RYGB) for treatment of obesity: a five-year study[J]. Surgery for Obesity and Related Diseases, 2019.
|
| [23] |
Jammu GS, Sharma R. A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure[J]. Obesity Surgery, 2016, 26(5): 926-932.
|
| [24] |
Ruiz-Tovar J, CarbajoMA, Jimenez JM, et al. Long-termfollow-up after sleeve gastrectomy versus roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized compar-ative study of weight loss and remission of co-morbidities[J]. Surgery Endoscopy. 2019, 33(2): 401-410.
|
| [25] |
Jens H, Abel B, Edo A, et al. A Longer Biliopancreatic Limb in Roux-en-Y Gastric Bypass Improves Weight Loss in the First Years After Surgery: Results of a Randomized Controlled Trial[J]. Obesity Surgery, 2018, 28(12): 3744-3755.
|
| [26] |
Murad, Abdon José, Cohen RV, De Godoy EP , et al. A Prospective Single-Arm Trial of Modified Long Biliopancreatic and Short Alimentary Limbs Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity[J]. Obesity Surgery, 2018, 28(3):599-605.
|
| [27] |
Boerboom A, Homan J, Aarts E, et al. A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial[J]. Surgery for Obesity and Related Diseases, 2018, 14(8): 60-69.
|
| [28] |
Miyachi T, Nagao M, Shibata C, et al. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes[J]. Surgery, 2016,159(5): 1360-1371.
|
| [29] |
Antonio Molinaro, Annika Wahlström, Hanns-Ulrich Marschall. Role of Bile Acids in Metabolic Control[J]. Trends in Endocrinology & Metabolism, 2017, 29(1): 31.
|
| [30] |
Ichiro, Ise, Naoki, et al. Changes in Enterohepatic Circulation after Duodenal-Jejunal Bypass and Reabsorption of Bile Acids in the Bilio-Pancreatic Limb.[J]. Obesity surgery, 2019, 29(6): 1901-1910..
|
| [31] |
Mika A, Kaska L, Proczko-Stepaniak M, et al. Evidence That the Length of Bile Loop Determines Serum Bile Acid Concentration and Glycemic Control After Bariatric Surgery[J]. Obesity Surgery, 2018, 28(11): 3405-3414.
|
| [32] |
Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The im-portance of the biliopancreatic limb length in gastric bypass: a sys-tematic review[J]. Surgery for Obesity and Related Diseases, 2019, 15(1): 43-50.
|
| [33] |
Erik Stenberg, Eva Szabo, Göran Ågren, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial[J]. Lancet, 2016, 387(10026): 1397-1404.
|
| [34] |
Chowbey P, Baijal M, Kantharia NS, et al. Mesenteric Defect Closure Decreases the Incidence of Internal Hernias Following Laparoscopic Roux-En-Y Gastric Bypass: a Retrospective Cohort Study[J]. Obesity Surgery, 2016, 26(9): 2029-2034.
|
| [35] |
Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: A population-based analysis[J]. Journal of the American College of Surgeons, 2004, 199(4): 543-551.
|
| [36] |
Nguyen NT, Paya M, Stevens CM, et al. The Relationship Between Hospital Volume and Outcome in Bariatric Surgery at Academic Medical Centers[J]. Annals of Surgery, 2004, 240(4): 586-593
|
| [37] |
Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: A systematic review and meta-analysis[J]. Surgery (St Louis), 2007, 142(4): 621-635.
|
| [38] |
Chang C. Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery[J]. N Engl J Med, 2009, 361(5): 445-454.
|
| [39] |
Darabi S, Talebpour M. Laparoscopic Gastric Plication Versus Mini-gastric Bypass Surgery in the Treatment of Morbid Obesity: A Randomized Clinical Trial[C]// 18th World Congress of the, 2013.
|
| [40] |
Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect[J]. Obesity Surgery, 2014, 24(9): 1552-62.
|
| [41] |
Seetharamaiah S, Tantia O, Goyal G, et al. LSG vs OAGB—1Year Follow-up Data—a Randomized Control Trial[J]. Obesity Surgery, 2017, 27(4): 1-7.
|